Navigation Links
Spaulding Clinical to Showcase First Cloud-based Cardiac Safety Solution Fully Integrated with Medidata Clinical Cloud at DIA
Date:6/12/2013

West Bend, WI (PRWEB) June 12, 2013

"Spaulding Clinical is focused on solutions that deliver speed, unprecedented quality and lower drug development costs. The integration that we offer with Medidata Solutions delivers on this for our clients with the added-value of immediate access to 12-lead electrocardiogram (ECG) interpretations, measurements, and waveforms, in the Medidata Rave system,” states Daniel Selness, General Manager and Sr. Vice President, Clinical Research for Spaulding Clinical.

“Spaulding Clinical and Medidata continue to drive new levels of productivity in clinical research with cloud-based technology, first with the integration of Spaulding’s clinical pharmacology data with Medidata Rave, and now with the integration of their cardiac safety clinical data,” states Glen de Vries, president of Medidata Solutions. “Our collaboration will benefit both sponsors and CROs who are looking for innovative solutions that drive quality up and costs down.”

“This seamless interface demonstrates the power of interoperable systems built on open standards. Through the Medidata Rave Web Services API, Medidata has enabled Spaulding Clinical to integrate its cardiac safety solution with the Medidata platform, providing a consistent user experience, resulting in higher quality study data for sponsors,” states Brock Heinz, Innovation Leader for Spaulding Clinical.

Spaulding Clinical has been recognized by Medidata Solutions as a Medidata Technology Partner since 2010, after leveraging Medidata Web Services application programming interfaces (APIs) to enable automatic study data transfer from the Spaulding Clinical Phase I EDC system to Rave. Spaulding Clinical pioneered the first fully electronic integration of Phase I study data directly into Medidata Rave, removing human data transcription errors and demonstrating significant cost and time savings.

Spaulding Clinical will be demonstrating their solutions at both the Medidata booth (#805) and Spaulding booth (#2203) at the DIA meeting, June 24-26th in Boston. Visit Spauldingclinical.com to view Spaulding’s quality metrics.

About Spaulding Clinical Research, LLC

Spaulding Clinical Research LLC, a change agent in the clinical research and medical device industries, is focused on driving perpetual value for its clients through technology and process innovation that delivers speed, unprecedented quality and lower costs.

Spaulding Clinical Research operates a 105-bed clinical pharmacology unit with 96, 12-lead ECG, telemetry beds in West Bend, Wisconsin, USA. The facility is paperless, using a customized Phase I Electronic Data Capture system with bi-directional interfaces to clinical lab, bedside devices and telemetry. Spaulding Biometrics provides full-service biostatistics, data management and medical writing services.

As a Phase I-IV centralized cardiac safety provider, Spaulding Clinical offers project management, expert cardiologist ECG over-read and a complete suite of state-of-the-art equipment provisioning, including the cloud-based Spaulding webECGTM Management Solution with the purpose-built Spaulding Model 1000iQ Electrocardiograph.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10823961.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Spaulding Clinical Research Partners With Verified Clinical Trials Protecting Clinical Trials From Dual Enrollment
2. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
3. Positive Clinical Study Results for BSPs HyperQ Technology
4. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
5. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
6. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
7. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
8. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
9. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
10. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
11. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , ... December 09, 2016 , ... There’s a winning ... 2016 by the Orange County Register, after winning the award last year as well. ... sought-after employer. President and COO Daniel Vesely pointed to the tech company’s upbeat environment ...
(Date:12/9/2016)... , Dec. 9, 2016  A platform ... University are moving one step closer to becoming ... applications. OrthoMend Research, Inc., a start-up company from ... the exclusive license for these novel absorbable bone ... develop them for commercial use. The company has ...
(Date:12/8/2016)...  The Board of Directors of the Pittsburgh ... only pure life sciences investment firm, today ... succession plan developed by the Nominating and Governance Committee ... (Jim) F. Jordan is selected to serve as ... Manzetti , who is elected to the position of ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... the business of innovation is taking over sports. On Thursday, December 15th a ... how technology is disrupting the playing field at a Smart Talk session. Smart ...
Breaking Biology Technology:
(Date:11/29/2016)... 29, 2016 BioDirection, a privately held medical ... the objective detection of concussion and other traumatic brain ... completed a meeting with the U.S. Food and Drug ... Pre-Submission Package. During the meeting company representatives reviewed plans ... precursor to commencement of a planned pilot trial. ...
(Date:11/24/2016)... , Nov. 23, 2016 Cercacor today introduced ... and their trainers non-invasively measure hemoglobin, Oxygen ... Rate, and Respiration Rate in approximately 30 seconds. Smaller ... easy and immediate access to key data about their ... a training regimen. Hemoglobin carries oxygen ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
Breaking Biology News(10 mins):